SciELO - Scientific Electronic Library Online

 
vol.33 issue2Endocrine alterations and cardiovascular risk in CKD: Is there a link?Improvement of therapeutic compliance in haemodialysis patients with poor phosphorus control and adherence to treatment with binders: COMQUELFOS study author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Nefrología (Madrid)

On-line version ISSN 1989-2284Print version ISSN 0211-6995

Abstract

GARCIA-AGUDO, Rebeca; AOUFI-RABIH, Sami; BARRIL-CUADRADO, Guillermina  and  GRUPO DE VIRUS EN DIALISIS DE LA SOCIEDAD ESPANOLA DE NEFROLOGIA. SHECTS multi-centre Spanish study: liver situation of patients with chronic hepatitis from HCV on renal replacement therapy with haemodialysis. Nefrología (Madr.) [online]. 2013, vol.33, n.2, pp.188-195. ISSN 1989-2284.  https://dx.doi.org/10.3265/Nefrologia.pre2012.Nov.11668.

Introduction: Chronic hepatitis C in dialysis patients is higher than in the general population. The SHECTS study has the goal of analysing the level of examination and follow-up of patients with chronic hepatitis C virus (HCV) infections on haemodialysis, and to determine the current prevalence of these patients. Method: A national, multicentre, cohort study carried out between September 2010 and September 2011. We sent a data collection folder to all Spanish haemodialysis units to include information regarding each centre and the nephrological/hepatological situation of their HCV-positive patients. Results: A total of 187 haemodialysis units (71 hospital-based) participated in the study. The global prevalence of HCV was estimated at 5.6%. The most common cause of chronic kidney disease was glomerular (25%); of the 72.1% of patients who had undergone a renal biopsy, 23.2% had glomerulonephritis that could have been associated with HCV. Genotyping had not been carried out in 64%, liver ultrasound had not been applied in 61.3%, and liver biopsies were not performed in 87.7%. One-third of all patients received care from a gastroenterologist. Antiviral treatment was administered to 26.6% of patients, with a sustained viral response in 35.3% and suspension of treatment in 67.4%. Conclusion: The prevalence of HCV in patients on haemodialysis in Spain has decreased considerably in the last decade to the point of reaching similar rates to those of neighbouring countries. These patients receive incomplete analyses of liver condition, and individuals who receive antiviral treatment and untreated patients constitute a large proportion, despite having low viral loads and being candidates for kidney transplants.

Keywords : Hepatitis C; Haemodialysis; Chronic kidney disease.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License